Date: Jan 22, 2014 Source: (
click here to go to the source)
Jan 22, 2014- Microvi Biotechnologies announced today that it has been awarded a $1.5 million grant from the National Institute of Environmental Health Sciences (NIEHS) to demonstrate at scale a novel technology for the treatment of 1,4 dioxane in water. This follows on the success of work completed during the Phase I grant, where a prototype was developed and tested of a first-of-its-kind biological treatment technology for dioxane degradation called MB-DX™.
"1,4-Dioxane is among the most widely detected organic contaminants in groundwater and drinking water, with 13% of US drinking water sources tested in 2013 showing evidence of 1,4-dioxane. Available treatment solutions are expensive and energy intensive and often have inconsistent performance records." said Mr. Thomas Mohr, Senior Hydrologist with the Santa Clara Valley Water District and a thought leader in the field of 1,4-Dioxane. "Microvi's MB-DX™ technology uses 1,4-Dioxane degrading microbes in a way that is effective and reliable and overcomes common challenges to bioreactor performance such as system stability and clogging."
"I congratulate Microvi Biotechnologies in Hayward and their CEO Dr. Fatemeh Shirazi on receiving this federal grant to help them pursue the development of a critical technology to keep our water safe," said Congressman Swalwell (CA-15). "Technological innovations like the sustainable solutions developed at Microvi are driving our economic growth in the Bay Area and I will keep advocating for strong public-private partnerships to support this sector."
